Of note, NAP-2 related effects are independent from the stroke risk assessed using the CHA2DS2-VASc score, which might help identify an additional subset of AF patients prone to thromboembolic events despite oral anticoagulation. The gene discussed is PPBP; the disease is stroke disorder.